Insulet Stock Options

PODD Stock  USD 349.56  1.13  0.32%   
Insulet's latest option contracts expiring on October 17th 2025 are carrying combined implied volatility of 0.26 with a put-to-call open interest ratio of 0.58 over 31 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on October 17th 2025. The total put volume is at 105, with calls trading at the volume of 247. This yields a 0.43 put-to-call volume ratio.

Open Interest Against October 17th 2025 Option Contracts

The chart above shows Insulet's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Insulet's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Insulet's option, there is no secondary market available for investors to trade.

Insulet Maximum Pain Price Across 2025-10-17 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Insulet close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, Insulet's option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on Insulet

Analyzing Insulet's in-the-money options over time can help investors to take a profitable long position in Insulet regardless of its overall volatility. This is especially true when Insulet's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Insulet's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Insulet's stock while costing only a fraction of its price.
Insulet's stock options are financial instruments that give investors the right to buy or sell shares of Insulet common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Insulet stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Insulet's stock price goes up or down, the stock options follow.
At present, Insulet's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Total Equity is expected to grow to about 120.8 K, whereas Other Stockholder Equity is forecasted to decline to about 643.5 M.

Insulet In The Money Call Balance

When Insulet's strike price is surpassing the current stock price, the option contract against Insulet stock is said to be in the money. When it comes to buying Insulet's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Insulet are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Insulet Current Options Market Mood

Insulet's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Insulet Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Insulet's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Insulet's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Insulet contract

Base on the Rule 16, the options market is currently suggesting that Insulet will have an average daily up or down price movement of about 0.0163% per day over the life of the 2025-10-17 option contract. With Insulet trading at USD 349.56, that is roughly USD 0.0568. If you think that the market is fully incorporating Insulet's daily price movement you should consider buying Insulet options at the current volatility level of 0.26%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Insulet options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Insulet calls. Remember, the seller must deliver Insulet stock to the call owner when a call is exercised.

Insulet Option Chain

When Insulet's strike price is surpassing the current stock price, the option contract against Insulet stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Insulet's option chain is a display of a range of information that helps investors for ways to trade options on Insulet. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Insulet. It also shows strike prices and maturity days for a Insulet against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
PODD251017C004400000440.00.0 - 4.44.4Out
Call
PODD251017C004300000430.00.0 - 2.052.05Out
Call
PODD251017C004200008420.00.0 - 1.350.35Out
Call
PODD251017C004100000410.00.2 - 1.50.05Out
Call
PODD251017C004000001400.00.45 - 1.91.05Out
Call
PODD251017C003900000390.00.9 - 2.652.3Out
Call
PODD251017C003800002380.01.85 - 3.72.18Out
Call
PODD251017C003700004370.03.8 - 5.24.32Out
Call
PODD251017C0036000012360.06.5 - 8.97.5Out
Call
PODD251017C00350000124350.010.9 - 12.710.9Out
Call
PODD251017C00340000134340.017.2 - 19.317.4In
Call
PODD251017C00330000288330.024.6 - 27.022.8In
Call
PODD251017C003200002320.029.9 - 36.631.0In
Call
PODD251017C003000009300.048.4 - 54.250.59In
 Put
PODD251017P004400000440.086.8 - 94.586.8In
 Put
PODD251017P004300000430.078.4 - 84.578.4In
 Put
PODD251017P004200000420.068.5 - 74.568.5In
 Put
PODD251017P004100000410.057.8 - 64.557.8In
 Put
PODD251017P004000000400.047.3 - 54.447.3In
 Put
PODD251017P003900000390.037.9 - 45.037.9In
 Put
PODD251017P003800000380.028.8 - 36.028.8In
 Put
PODD251017P003700000370.021.6 - 25.321.6In
 Put
PODD251017P003600001360.015.5 - 18.618.15In
 Put
PODD251017P003500004350.09.9 - 13.111.1Out
 Put
PODD251017P0034000025340.06.6 - 7.67.2Out
 Put
PODD251017P0033000019330.03.5 - 6.14.1Out
 Put
PODD251017P00320000268320.02.15 - 3.72.75Out
 Put
PODD251017P003100008310.00.25 - 4.51.55Out
 Put
PODD251017P003000007300.00.6 - 3.90.8Out
 Put
PODD251017P002900006290.00.0 - 4.81.35Out
 Put
PODD251017P002700001270.00.0 - 4.70.93Out

Insulet Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

Insulet Market Cap Over Time

   Market Cap   
       Timeline  

Insulet Total Stockholder Equity

Total Stockholder Equity

1.27 Billion

At present, Insulet's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.

Insulet Corporate Management

Philip HildaleSenior CareProfile
Andrew IsaacsonSenior DevelopmentProfile
Laetitia CousinQuality AffairsProfile
Carolyn SleethSenior ManagerProfile
When determining whether Insulet is a strong investment it is important to analyze Insulet's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insulet's future performance. For an informed investment choice regarding Insulet Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Insulet. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in national income and product accounts.
For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insulet. If investors know Insulet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insulet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.88)
Earnings Share
3.28
Revenue Per Share
33.594
Quarterly Revenue Growth
0.329
Return On Assets
0.0775
The market value of Insulet is measured differently than its book value, which is the value of Insulet that is recorded on the company's balance sheet. Investors also form their own opinion of Insulet's value that differs from its market value or its book value, called intrinsic value, which is Insulet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insulet's market value can be influenced by many factors that don't directly affect Insulet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insulet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insulet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insulet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.